Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-000396·Myers Michael
Schedule 13D ownership disclosure
QUOIN PHARMACEUTICALS LTD
Ordinary Shares, no par value per share (represented by American Depositary Shares) · CUSIP: 74907L300
Event date: 2024-12-23
- Filing-level shares
- 622,573.00
- Percent of class
- 6.9%
- Michael MyersReported CIK 0001959547
Shares: 622,573.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-000396
- Form type
- SCHEDULE 13D
- Filer
- Myers Michael
- CIK
- CIK 1959547
- Filed
- Jan 02, 2025
- Reporting period
- Dec 23, 2024
- Description
- Schedule 13D beneficial ownership